Siren, L.L.C. Applied Therapeutics Inc. Transaction History
Siren, L.L.C.
- $2.26 Trillion
- Q4 2024
A detailed history of Siren, L.L.C. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 1,633,768 shares of APLT stock, worth $816,884. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,633,768
Previous 1,633,768
-0.0%
Holding current value
$816,884
Previous $13.9 Billion
89.93%
% of portfolio
0.06%
Previous 0.69%
Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$5.75 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$5 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$4.81 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$4.41 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$4.38 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $24M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...